Mammography is the standard screening tool for breast cancer. AI systems are trained on large sets of annotated mammograms — normal and abnormal, with biopsy-confirmed outcomes — until they learn the visual patterns that separate benign findings from suspicious ones. Given a new image, the model highlights the regions it judges concerning and assigns a risk score.
This does not happen in isolation. In clinical practice, AI acts as a second reader: it looks at every mammogram alongside the radiologist, drawing attention to subtle lesions that could go unnoticed — especially in dense breast tissue, where cancer can hide behind overlapping tissue.
What the evidence shows
- A Swedish trial reported around 20% more cancers detected with AI double-reading
- A large American study reported fewer false positives with AI-supported screening
- AI performs especially well on subtle, early tumours
- Studies compare AI against biopsy-confirmed outcomes, not guesses
AI is a decision aid, not a diagnosis. Every AI flag is reviewed by a human radiologist before any further step.